VolitionRx Limited (VNRX) Earnings History
Annual and quarterly earnings data from 2004 to 2025
Loading earnings history...
VNRX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
VNRX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 100.0% | -1228.6% | -1352.2% |
| 2024 | 100.0% | -2190.9% | -2186.3% |
| 2023 | 100.0% | -4641.8% | -4555.5% |
| 2022 | 100.0% | -10372.4% | -9879.1% |
| 2021 | 100.0% | -31469.0% | -29782.5% |
Download Data
Export VNRX earnings history in CSV or JSON format
Free sign-in required to download data
VolitionRx Limited (VNRX) Earnings Overview
As of May 8, 2026, VolitionRx Limited (VNRX) reported trailing twelve-month net income of -$23M, reflecting +29.0% year-over-year growth. The company earned $-4.37 per diluted share over the past four quarters, with a net profit margin of -1352.2%.
Looking at the long-term picture, VNRX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$10,947 in fiscal 2010.
VolitionRx Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including EXAS (-$208M net income, -6.4% margin), ILMN ($853M net income, 19.6% margin), NTRA (-$208M net income, -9.0% margin), VNRX has room to improve margins relative to the peer group. Compare VNRX vs EXAS →
VNRX Earnings vs Peers
Earnings metrics vs comparable public companies
VNRX Historical Earnings Data (2004–2025)
22 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$23M | +13.4% | -$21M | $-4.40 | -1352.2% | -1228.6% |
| 2024 | -$27M | +23.6% | -$27M | $-6.20 | -2186.3% | -2190.9% |
| 2023 | -$35M | -16.7% | -$36M | $-10.00 | -4555.5% | -4641.8% |
| 2022 | -$30M | -12.9% | -$32M | $-11.00 | -9879.1% | -10372.4% |
| 2021 | -$27M | -31.8% | -$28M | $-10.20 | -29782.5% | -31469.0% |
| 2020 | -$20M | -26.4% | -$21M | $-9.00 | -151508.3% | -158176.2% |
| 2019 | -$16M | +10.6% | -$16M | $-8.20 | -94168.5% | -93840.2% |
| 2018 | -$18M | -21.9% | -$18M | $-11.40 | - | - |
| 2017 | -$15M | -24.1% | -$15M | $-11.20 | - | - |
| 2016 | -$12M | -24.9% | -$12M | $-10.40 | - | - |
See VNRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VNRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VNRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVNRX — Frequently Asked Questions
Quick answers to the most common questions about buying VNRX stock.
Is VNRX growing earnings?
VNRX EPS is $-4.37, with earnings growth accelerating to +29.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-23M.
What are VNRX's profit margins?
VolitionRx Limited net margin is -1352.2%, with operating margin at -1228.6%. Below-average margins reflect competitive or cost pressures.
How consistent are VNRX's earnings?
VNRX earnings data spans 2004-2025. The accelerating earnings trend is +29.0% YoY. Historical data enables comparison across business cycles.